Biotech Values

[rkrw]

What do you make of the abstract I linked to?

I've spoken with a small handful of docs unconnected to pymx and all said the opposite of you on both thrombin and Protamine.

I do appreciate the issue of pricing and it will take convincing data to justify a huge price premium, not theoretical data.

In any case, if there's a potential market for a replacement it will show up in the head to head study.